Tag: immunotherapy

Mast Cells

Allakos Announces New Antibody that Prevents Anaphylaxis in Humanized Mice

Company will initiate human trials next year.
Owner with Cat Allergy

Experimental Treatment for Cat Allergies May Pave the Way for Treatment...

This approach might also be effective for other types of allergies, including food allergies.
INT301 Toothpaste OMIT

Intrommune’s Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment

Company is developing a patient-friendly treatment platform for peanut and other food allergies.
Viaskin Peanut

Private Law Firm to Investigate Claims on Behalf of Investors in...

It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.
Sublingual Tablet

ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy

Sublingual Immunotherapy is administered via medications placed under the tongue.
Viaskin Patch

DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...

Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
mother-and-daughter-brushing-teeth

Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial

Phase 1 study amended after two cohorts show no significant adverse events.
Moonlight Therapeutics Microneedle Patch

Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy

Study finds five-minute weekly dose of peanut protein through the skin, delivered by a novel microneedle technology, was superior in desensitizing peanut-allergic mice compared to administering the protein through a skin patch.
Viaskin-Patch

Safety of Viaskin Peanut Patch Therapy Improved Over 3-Year Study

Reactions decreased over study duration.